These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 15996331)
1. [Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment]. Xu JM; Zhu BD; Mangia A; Simone G; Montemurro S; Giuliani F; Maiello E; Colucci G; Paradiso A Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):312-5. PubMed ID: 15996331 [TBL] [Abstract][Full Text] [Related]
2. Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients. Paradiso A; Xu J; Mangia A; Chiriatti A; Simone G; Zito A; Montemurro S; Giuliani F; Maiello E; Colucci G Int J Cancer; 2004 Aug; 111(2):252-8. PubMed ID: 15197779 [TBL] [Abstract][Full Text] [Related]
3. CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen. Silvestris N; Simone G; Partipilo G; Scarpi E; Lorusso V; Brunetti AE; Maiello E; Paradiso A; Mangia A Int J Mol Sci; 2014 Sep; 15(9):15767-77. PubMed ID: 25198900 [TBL] [Abstract][Full Text] [Related]
4. Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy. Kostopoulos I; Karavasilis V; Karina M; Bobos M; Xiros N; Pentheroudakis G; Kafiri G; Papakostas P; Vrettou E; Fountzilas G BMC Cancer; 2009 Sep; 9():339. PubMed ID: 19775480 [TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases. Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475 [TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer. Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123 [TBL] [Abstract][Full Text] [Related]
8. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
9. Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study. Koopman M; Venderbosch S; van Tinteren H; Ligtenberg MJ; Nagtegaal I; Van Krieken JH; Punt CJ Eur J Cancer; 2009 Jul; 45(11):1999-2006. PubMed ID: 19457654 [TBL] [Abstract][Full Text] [Related]
10. Modified Irinotecan/5FU/Leucovorin therapy in advanced colorectal cancer and predicting therapeutic efficacy by expression of tumor-related enzymes. Yanagisawa Y; Maruta F; Iinuma N; Ishizone S; Koide N; Nakayama J; Miyagawa S Scand J Gastroenterol; 2007 Apr; 42(4):477-84. PubMed ID: 17454858 [TBL] [Abstract][Full Text] [Related]
11. [Clinical significant of semiquantificating DNA topoisomerase- I mRNA in colorectal cancer]. Ishida H; Shirakawa K; Ohsawa T; Hayashi Y; Okada N; Nakada H; Yokoyama M Gan To Kagaku Ryoho; 2005 Sep; 32(9):1295-9. PubMed ID: 16184927 [TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. Johnston PG; Benson AB; Catalano P; Rao MS; O'Dwyer PJ; Allegra CJ J Clin Oncol; 2003 Mar; 21(5):815-9. PubMed ID: 12610179 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer. Corsi DC; Ciaparrone M; Zannoni G; Mancini M; Cassano A; Specchia M; Pozzo C; Martini M; Barone C Eur J Cancer; 2002 Mar; 38(4):527-34. PubMed ID: 11872345 [TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer. Meropol NJ; Gold PJ; Diasio RB; Andria M; Dhami M; Godfrey T; Kovatich AJ; Lund KA; Mitchell E; Schwarting R J Clin Oncol; 2006 Sep; 24(25):4069-77. PubMed ID: 16943524 [TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer. Bendardaf R; Lamlum H; Elzagheid A; Ristamäki R; Pyrhönen S Oncol Rep; 2005 Sep; 14(3):657-62. PubMed ID: 16077970 [TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil. Aschele C; Debernardis D; Bandelloni R; Cascinu S; Catalano V; Giordani P; Barni S; Turci D; Drudi G; Lonardi S; Gallo L; Maley F; Monfardini S Ann Oncol; 2002 Dec; 13(12):1882-92. PubMed ID: 12453856 [TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients. Marcuello E; Altés A; del Rio E; César A; Menoyo A; Baiget M Int J Cancer; 2004 Dec; 112(5):733-7. PubMed ID: 15386371 [TBL] [Abstract][Full Text] [Related]
19. Relevance of dihydropyrimidine-dehydrogenase and thymidylate-synthase in patients with pancreatic neuroendocrine neoplasms treated with 5-FU-based chemotherapy. Krug S; Boch M; Nimphius W; Gress TM; Michl P; Rinke A Pancreatology; 2017; 17(1):139-145. PubMed ID: 28027897 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. Allegra CJ; Paik S; Colangelo LH; Parr AL; Kirsch I; Kim G; Klein P; Johnston PG; Wolmark N; Wieand HS J Clin Oncol; 2003 Jan; 21(2):241-50. PubMed ID: 12525515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]